The new basophil-microarray based allergy assay is the brainchild of researchers in The University of Nottingham’s Schools of Pharmacy and Biosciences, in collaboration with colleagues in the Centre for Respiratory Research at Nottingham City Hospital.
Their innovation has won them a Da Vinci award in the Breakthrough Technology category, which comes with a £15,000 prize to use towards furthering their research.
Now in their second year, the Da Vinci Awards, which are run through Loughborough University, recognise collaborative projects that lead to the potential commercialisation of healthcare innovations to save lives and improve services to patients.
Dr Franco Falcone, Associate Professor in The University of Nottingham’s School of Pharmacy, said that he and his colleagues were thrilled to have won a Da Vinci award as it would be crucial in acting as a springboard to the further progression of their research.
He added: “Getting funding from research councils for such a project is not always easy, so this is why Da Vinci award funding is ideal because it’s seed funding that we can then use to underpin a major grant application.”
The new technology developed at Nottingham is a lab-based, in-vitro test to mimic human allergic reaction that could be used as an alternative to the traditional skin-prick test. It can test up to 5,000 different food or inhalant allergens that could cause an allergic reaction in a patient and the researchers are hoping it could also be developed as a diagnostic tool for parasitic infections.
It works by adding tiny dots of allergen molecules to paper on a glass slide. A drop of the patient’s blood is added before the slide is incubated with the cells causing the symptoms of allergy. Cellular activation can then be analysed to discover which of the allergens are prompting the release of histamine and other chemicals indicative of allergic reaction in the patient’s blood.
Dr Marcos Alcocer, a lecturer in the School of Biosciences, said: “The whole idea is to trace what we call our immunological profile, the finger print of our immune system which tells us how we react to the things which we are surrounded by.
“Our technology is one step towards the ultimate goal of being able to have a full in-vitro diagnostic test for allergy. What we have to do now is examine the results of our test further and then assess how well it works compared to the gold standard techniques currently used for diagnosis. We will then be in a very good position for commercialisation.”
Researchers from The University of Nottingham were also highly commended in the Clinical Impact category of the Da Vinci Awards. A collaboration between Professor Ian Ellis in the University’s School of Molecular Medical Sciences and colleagues at Nottingham Trent University and University Hospital Nottingham has led to the development of a breast cancer prognostic tool.
Nottingham Prognostic Index offers a personalised approach to medicine by classifying patients into groups according to their tumour biology, provides information about the patients’ most probable survival outcome and guides clinicians in the most appropriate form of treatment.
The tool should reduce the incidence of over-treatment and minimise the harmful side-effects for patients and is due to be commercialised by a spin-out company Nottingham Prognostics.
Anna Seddon, Manager of the Da Vinci Network, said: “The excellent response to the Da Vinci Awards reinforces the importance of building interdisciplinary and inter-institutional collaboration to address critical issues in healthcare. The quality of applicants reflects the wealth of activity in healthcare innovation developed here in the East Midlands.”
An awards ceremony for the Da Vinci Awards was held last night (November 25) at Loughborough University, compered by BBC newsreader Kay Alexander. The after dinner speaker for the event was Professor W Angus Wallace, Professor of Orthopaedic and Accident Surgery at The University of Nottingham, whose special interests lie in the fields of shoulder surgery, sports injuries, osteoporosis, biomechanics and research into passenger safety in aircraft and cars. Guests included senior figures from the East Midlands’ clinical, research and health care industry communities.
A video outlining the work of the winners of the Breakthrough Award and the development of their lab-based test for allergies can be found on the web at www.davinci-net.org
Emma Thorne | alfa
One gene closer to regenerative therapy for muscular disorders
01.06.2017 | Cincinnati Children's Hospital Medical Center
The gut microbiota plays a key role in treatment with classic diabetes medication
01.06.2017 | University of Gothenburg
An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.
Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...
Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.
Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...
Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.
As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...
Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.
With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...
Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine
Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...
19.06.2017 | Event News
13.06.2017 | Event News
13.06.2017 | Event News
23.06.2017 | Physics and Astronomy
23.06.2017 | Physics and Astronomy
23.06.2017 | Information Technology